Share on LinkedInShare on LinkedIn

ARTICLE · 25 JANUARY 2024

Market Intelligence Thought Leadership Award Winner

2023 Year In Review: Life Sciences In Canada

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

The Canadian life sciences sector saw several notable developments in 2023. This article summarizes a number of the more remarkable court decisions...

CanadaIntellectual Property

The Canadian life sciences sector saw several notable developments in 2023. This article summarizes a number of the more remarkable court decisions, as well as other life sciences-related developments from 2023.

1. Decisions under the PM(NOC) Regulations

The Federal Court of Appeal and Federal Court issued several decisions in respect of patent infringement and invalidity actions, including in actions commenced under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations ("PM(NOC) Regulations"). We highlight seven of these decisions below.

Janssen Inc. v. Apotex Inc., 2023 FCA 253: Serving serial NOAs raising different issues found to be an abuse of process

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from